BMEYE B.V.

AMSTERDAM, June 14, 2011 - - New Algorithms Offered in ccNexfin Combined With Noninvasive Beat-to-beat Cardiac Output (CO), Blood Pressure (BP) and Masimo's Breakthrough Noninvasive Hemoglobin (SpHb) and Oxygen Saturation (SpO2) Measurements BMEYE B.V., the inventor of noninvasive, beat-to-beat cardiac output and blood pressure monitoring, announces the launch of DO2I - the delivery of oxygen to the tissues.

AMSTERDAM, December 2, 2010 - BMEYE B.V., the innovators of a totally noninvasive combined beat-to-beat blood pressure and cardiac output monitoring system, and PULSION Medical Systems AG, a leading specialist in minimally invasive critical care and cardiovascular patient monitoring, have reached agreement on a worldwide, non-exclusive license which allows BMEYE's technology to be integrated into PULSION's next generation hemodynamic patient monitoring solution.

AMSTERDAM, November 18, 2010 - BMEYE B.V., the innovators of combined totally noninvasive, beat-to-beat blood pressure and cardiac output monitoring announces FDA clearance and the United States launch of the BMEYE ccNexfin-the first totally noninvasive cardiovascular monitor with blood pressure, cardiac output, and Masimo rainbow(R) SET Pulse CO-Oximetry(TM) measurements.

AMSTERDAM, June 10, 2010 - BMEYE B.V., the innovator of combined noninvasive, beat-to-beat blood pressure and cardiac output monitoring received the prestigious European Red Herring Top 100 Award 2010 www.herring100.com/RHE2010/rhe2010winners/rhe2010winners.html).

AMSTERDAM - - New Investors Earlybird and 360 Capital Partners led the Round BMEYE B.V., the non-invasive cardiovascular monitoring company, today announced the successful completion of its Series B financing round, raising EUR 6 million.